199 related articles for article (PubMed ID: 28574302)
21. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcomes of de novo acute myeloid leukemia in Thai patients.
Niparuck P; Chuncharunee S; Ungkanont A; Udomtrupayakul U; Aungchaisuksiri P; Rerkamnuatchoke B; Jootar S; Atichartakarn V
J Med Assoc Thai; 2009 Sep; 92(9):1143-9. PubMed ID: 19772172
[TBL] [Abstract][Full Text] [Related]
23. Clinico-pathological characteristics of myeloid sarcoma at diagnosis and during follow-up: report of 12 cases from a single institution.
Breccia M; Mandelli F; Petti MC; D'Andrea M; Pescarmona E; Pileri SA; Carmosino I; Russo E; De Fabritiis P; Alimena G
Leuk Res; 2004 Nov; 28(11):1165-9. PubMed ID: 15380340
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients.
Kawamoto K; Miyoshi H; Yoshida N; Takizawa J; Sone H; Ohshima K
Am J Surg Pathol; 2016 Nov; 40(11):1473-1483. PubMed ID: 27631510
[TBL] [Abstract][Full Text] [Related]
25. Aleukemic cutaneous myeloid sarcoma.
Aboutalebi A; Korman JB; Sohani AR; Hasserjian RP; Louissaint A; Le L; Kraft S; Duncan LM; Nazarian RM
J Cutan Pathol; 2013 Dec; 40(12):996-1005. PubMed ID: 24274424
[TBL] [Abstract][Full Text] [Related]
26. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic risk grouping by the monosomal karyotype classification is superior in predicting the outcome of acute myeloid leukemia undergoing allogeneic stem cell transplantation in complete remission.
Hemmati PG; Schulze-Luckow A; Terwey TH; le Coutre P; Vuong LG; Dörken B; Arnold R
Eur J Haematol; 2014 Feb; 92(2):102-10. PubMed ID: 24138573
[TBL] [Abstract][Full Text] [Related]
28. Somatic ASXL1 p.R693X mutation identified by next generation sequencing in isolated myeloid sarcoma involving the mediastinum.
Fang L; Cui Y; Mi Y; Ru K; Sun Q; Qin T; Xu Z; Wang J; Xiao Z
Curr Med Res Opin; 2020 Jun; 36(6):1003-1007. PubMed ID: 32286099
[No Abstract] [Full Text] [Related]
29. Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle?
Pramanik R; Tyagi A; Chopra A; Kumar A; Vishnubhatla S; Bakhshi S
Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e249-e254. PubMed ID: 29680411
[TBL] [Abstract][Full Text] [Related]
30. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
[TBL] [Abstract][Full Text] [Related]
31. Breast myeloid sarcoma presenting as a palpable breast lump after allogeneic stem cell transplantation for acute myelomonocytic leukemia: a rare case report.
Huang C; Fei S; Yao J; Chen P; Luo J; Wang Y; Li J; Wang W
World J Surg Oncol; 2021 Sep; 19(1):289. PubMed ID: 34579724
[TBL] [Abstract][Full Text] [Related]
32. Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant.
Ahn JS; Kim JY; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Ann Hematol; 2016 Jan; 95(2):301-10. PubMed ID: 26537612
[TBL] [Abstract][Full Text] [Related]
33. Myeloid sarcoma: an unusual presentation for acute tracheal stenosis.
Podgaetz E; Kriegsmann M; Dincer EH; Allan JS
Clin Respir J; 2016 Nov; 10(6):800-804. PubMed ID: 25763656
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract][Full Text] [Related]
35. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
[TBL] [Abstract][Full Text] [Related]
36. Allogeneic hematopoietic stem cell transplantation for adult AML patients with granulocytic sarcoma.
Shimizu H; Saitoh T; Tanaka M; Mori T; Sakura T; Kawai N; Kanda Y; Nakaseko C; Yano S; Fujita H; Fujisawa S; Miyawaki S; Kanamori H; Okamoto S
Leukemia; 2012 Dec; 26(12):2469-73. PubMed ID: 22699453
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological analysis of myeloid sarcoma with megakaryocytic differentiation.
Nagamine M; Miyoshi H; Kawamoto K; Takeuchi M; Yamada K; Yanagida E; Kohno K; Ohshima K
Pathology; 2022 Jun; 54(4):442-448. PubMed ID: 34852914
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors for therapy-related acute myeloid leukaemia (t-AML)--a single centre experience.
Suvajdžić N; Cvetković Z; Dorđević V; Kraguljac-Kurtović N; Stanisavljević D; Bogdanović A; Djunić I; Colović N; Vidović A; Elezović I; Tomin D
Biomed Pharmacother; 2012 Jun; 66(4):285-92. PubMed ID: 22401928
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.
Pfrepper C; Klink A; Behre G; Schenk T; Franke GN; Jentzsch M; Schwind S; Al-Ali HK; Hochhaus A; Niederwieser D; Sayer HG
J Cancer Res Clin Oncol; 2016 Jan; 142(1):317-24. PubMed ID: 26424692
[TBL] [Abstract][Full Text] [Related]
40. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
